Meet Us at the 16th Annual World Bispecific Summit

Recent scientific developments, particularly in antibody engineering, have led to numerous innovations in cancer immunotherapy and one of the most promising innovations has been the development of bispecific antibodies, as bispecific drugs make huge waves in multiple myeloma and lymphoma, so much so that they threaten cell therapy in multiple myeloma.

To celebrate the huge progression in the space, the 16th World Bispecific Summit is calling drug developers across discovery, preclinical and clinical development to join forces at this years summit and be part of the movement transforming the development of bi and multi-specific specific drugs to progress more drugs to approval status and to patients in need.

As over 150 key opinion leaders from the bi and multi-specific community convene in Boston, don’t miss your opportunity to be at the epicentre of the discussion and networking as we delve into novel targets, next generation formats, AI in bispecific and translational and clinical development. There is no other forum out there that can deliver a one-stop-shop on all things bispecifics.

Drop by our booth if you will be attending the 16th World Bispecific Summit! Our specialists are excited to meet our customers face-to-face to discuss how Creative Biolabs can help develop and optimize your bi- and multi-specific therapeutics development. Feel free to leave your contact information and tell us your partnering needs!